Showing 6,005 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Side effects

Gilead Lawsuits: 41 HIV and PrEP Patients File California Personal Injury Case Over Gilead's TDF-Based Drugs

Editor's pick
Associated Press
12 April 2019
Starting treatment

US regulators approve new two-drug combination pill for HIV

News
11 April 2019
Antibody-based treatment

Monoclonal antibody may lead to long-term viral load reduction

News
11 April 2019
Treatment simplification strategies

FDA approves first two-drug complete regimen for HIV-infected patients who have never received antiretroviral treatment

Editor's pick
Food & Drug Administration
9 April 2019
Opportunistic infections

A Mysterious Infection, Spanning the Globe in a Climate of Secrecy

Editor's pick
New York Times
8 April 2019
Treatment guidelines

Avoiding Dolutegravir in Young Women With HIV: Time for a Rethink?

Editor's pick
MedPage Today
5 April 2019
Treatment simplification strategies

ViiV Healthcare announces Juluca (dolutegravir/rilpivirine) maintains HIV viral suppression at 148-weeks

Editor's pick
ViiV press release
5 April 2019
Adherence

'Vast majority' of elevated viral load episodes in pregnant women caused by non-adherence

Editor's pick
Healio
2 April 2019
Treatment simplification strategies

Viral suppression maintained with alternate-day dosing of efavirenz/tenofovir/emtricitabine

News
1 April 2019
Treatment simplification strategies

Two-antiretroviral maintenance failure - raltegravir regimens seem most vulnerable

Editor's pick
NATAP
29 March 2019
Access to healthcare

EACS Standard of Care meeting report – Tackling HIV and co-infections in Europe: towards common standards

News
29 March 2019
Contraception

Efavirenz and rifampicin together reduce levels of injectable contraception

Editor's pick
HIV i-Base
29 March 2019
Contraception

Double-dose levonorgestrel implant does not overcome interaction with efavirenz

Editor's pick
HIV i-Base
29 March 2019
Harm reduction

Opioid overdose deaths are rising among people with HIV in the United States

News
28 March 2019
Side effects

HIV Drugs With Fewer Side Effects Need More FDA Support

Editor's pick
HivPlusMag.com
27 March 2019
Pharmaceutical industry

Non-adherence to HIV treatment for cost-saving reasons reported by 8% in American study

News
27 March 2019
New & experimental HIV treatments

Why 1 Top Analyst Thinks Gilead Sciences Will Soar More Than 25%

Editor's pick
Motley Fool
24 March 2019
Weight gain & lipodystrophy

The impact of older antiretrovirals on fat redistribution and cardiovascular risk factors may be irreversible

News
21 March 2019
New & experimental HIV treatments

Trogarzo’s Effects on Hard-to-Treat HIV Are Stable Over Two Years

Editor's pick
Poz
20 March 2019
People with limited treatment options

South Africa: Shortage of drug puts thousands of Aids patients at risk

Editor's pick
Independent Online
15 March 2019
Viral load

More than 1 year to HIV control raises failure risk almost 10-fold

Editor's pick
NATAP
15 March 2019
Improving HIV care

Up to 95% virologic response rate with rapid ART in safety-net clinic

Editor's pick
NATAP
14 March 2019
Side effects

Inactive Ingredients in Medications Cause Trouble for Some

Editor's pick
Medscape (requires free registration)
14 March 2019
Drug-resistant TB

TB CAB statement on safety of using bedaquiline and delamanid together

Editor's pick
TB Online
14 March 2019